| 4.1 Death or bronchopulmonary dysplasia at 36 weeks PMA |
3 |
168 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.06 [0.88, 1.29] |
| 4.2 Mortality at 28 days PNA |
2 |
109 |
Risk Ratio (M‐H, Fixed, 95% CI) |
2.83 [0.60, 13.32] |
| 4.3 Mortality at 36 weeks PMA |
3 |
168 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.54 [0.63, 3.79] |
| 4.4 Mortality at hospital discharge |
3 |
168 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.84 [0.77, 4.37] |
| 4.5 Bronchopulmonary dysplasia at 28 days PNA |
2 |
109 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.15 [0.88, 1.50] |
| 4.6 Bronchopulmonary dysplasia at 36 weeks PMA |
3 |
168 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.99 [0.79, 1.25] |
| 4.7 Failure to extubate 3 days after initiation |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
| 4.8 Failure to extubate 7 days after initiation |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
| 4.9 Days of mechanical ventilation |
2 |
90 |
Mean Difference (IV, Fixed, 95% CI) |
9.26 [4.32, 14.21] |
| 4.10 Days on supplemental oxygen |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Totals not selected |
| 4.11 Hypertension |
2 |
135 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.34 [0.01, 8.13] |
| 4.12 Hyperglycemia |
2 |
98 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.66 [0.26, 1.66] |
| 4.13 Open‐label corticosteroids |
2 |
135 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.72 [0.72, 4.13] |
| 4.14 Culture confirmed infection |
2 |
92 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.27 [0.58, 2.76] |
| 4.15 Necrotizing enterocolitis |
2 |
98 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.75 [0.48, 6.35] |
| 4.16 Intraventricular hemorrhage (> grade II) |
3 |
168 |
Risk Ratio (M‐H, Fixed, 95% CI) |
2.00 [0.78, 5.18] |
| 4.17 Periventricular leucomalacia |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
| 4.18 Retinopathy of prematurity (any) |
2 |
98 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.83 [0.24, 2.92] |
| 4.19 Cerebral palsy in survivors assessed at 1‐3 years |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
| 4.20 Death or cerebral palsy at 1‐3 years |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
| 4.21 Bayley's MDI < ‐2 SD |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
| 4.22 Severe blindness |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
| 4.23 Abnormal neurodevelopmental outcome in survivors assessed (various definitions) |
3 |
143 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.09 [0.71, 1.70] |
| 4.24 Death or abnormal neurodevelopmental outcome (various definitions) |
3 |
168 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.44 [0.99, 2.07] |
